Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

scientific article published on 01 July 2006

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1464-5491.2006.01862.X
P698PubMed publication ID16842476

P50authorSimon HellerQ38550003
Johan JendleQ57302913
P2093author name stringPerriello G
Gall MA
Ross GP
Kølendorf K
Pavlic-Renar I
Philotheou A
P2860cites workThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupQ27861088
Insulins today and beyondQ34365284
New insulins in the treatment of diabetes mellitusQ34701220
Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetesQ34756826
Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.Q44946403
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimenQ44953752
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.Q45009681
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulinQ45118534
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulinQ45218162
Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.Q53899946
Reducing hypoglycaemia with insulin analoguesQ57413046
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human InsulinQ57599459
P433issue7
P921main subjectglucoseQ37525
type-1 diabetesQ124407
hypoglycemiaQ202758
insulin detemirQ410965
NPH insulinQ1929845
preproinsulinQ7240673
P304page(s)729-735
P577publication date2006-07-01
P1433published inDiabetic MedicineQ15758639
P1476titleInsulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
P478volume23